Drug intelligence / Profile preview

Micro V Probiotics

Development stage: Phase 2
Lead developer: Bio-Vet
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Micro V Probiotics is a dietary supplement designed to support vaginal, digestive, and immune health by promoting a healthy balance of bacteria. [1] It is a combination product containing various strains of beneficial bacteria, primarily from the Lactobacillus and Bifidobacterium genera. [1] The product is formulated to be "micro-V-iome friendly," catering specifically to the female intimate microbiome. [1] It is also being investigated in a clinical trial for its potential therapeutic effects in patients with Primary Biliary Cholangitis (PBC) who have a poor response to standard treatment. [2, 7, 9]

Brand names: Micro V ProbioticsQueen V Micro V-iome DD Probiotic

Beyond the preview

Go deeper on Micro V Probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micro V Probiotics.

Explore the full profile